封面
市场调查报告书
商品编码
1626555

全球医疗保健 3D 列印市场规模(按产品、技术、应用、地区、范围和预测)

Global Healthcare 3D Printing Market Size by Product, By Technology (Fused Deposition Modelling, Selective Laser Sintering, Stereolithography), By Application, By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

医疗保健 3D 列印市场规模及预测

2023 年医疗保健 3D 列印市场规模价值 33.8 亿美元,预计到 2031 年将达到 122.6 亿美元,2024 年至 2031 年的复合年增长率为 19.29%。

医疗保健 3D 列印是使用积层製造技术生产个人化医疗产品和植入物的过程。该技术可在骨科、关节置换和手术规划方面提供精确的、针对患者的解决方案。

该技术用于创建植入物、人工关节和手术前规划的解剖模型。个人化的植入物和手术器械可改善患者的治疗效果并简化手术程序。

未来的应用包括组织和器官的生物列印,以及义肢和植入物。它有可能推动再生医学和个人化治疗的进步,彻底改变疾病的治疗方式。

全球医疗保健 3D 列印市场动态

主要市场推动因素

技术进步:3D 列印技术的进步将透过提高精度、速度和材料能力来推动成长,扩大个人化植入物、义肢和手术规划的应用。

个人化医疗需求不断增长:随着人们寻求个人化的医疗保健解决方案,对客製化植入物和人工关节的需求不断增长,这些植入物和人工关节可以适应每个患者的需求,从而推动市场成长。

慢性病发病率上升:慢性病发病率不断上升,需要个人化的 3D 列印医疗设备等先进的替代治疗方法。

主要课题

监管障碍:取得3D列印医疗设备的各种法规和批准非常困难且耗时,阻碍了市场发展和产品开发。

成本高:3D 列印技术和材料的初始成本高,可能会限制其普及和广泛采用,尤其是在资源受限的医疗保健环境中。

材料限制:医疗保健领域可用于 3D 列印的材料数量仍然有限,从而降低了列印医疗设备和植入物的功能和寿命。

品质和标准化:保持一致的品质并满足 3D 列印医疗设备的严格要求非常困难,从而损害了其在临床环境中的可靠性和普遍采用。

主要趋势:

生物列印技术的进步:生物列印技术的进步使得创建复杂的组织和器官原型成为可能,突破了再生医学的界限。

与数位健康技术的融合:将 3D 列印与影像和 CAD 软体等数位健康工具相结合,将提高医疗器材製造和手术规划的准确性。

新兴市场的扩张:新兴市场医疗保健投资的增加推动了 3D 列印产业的成长,增加了世界获得最新医疗技术的机会。

目录

第 1 章全球医疗保健 3D 列印市场介绍

  • 市场介绍
  • 调查范围
  • 先决条件

第 2 章执行摘要

第3章 VERIFIED MARKET RESEARCH研究方法

  • 数据挖掘
  • 验证
  • 一次资料
  • 数据源列表

第4章 全球医疗3D列印市场展望

  • 概述
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力模型
  • 价值链分析

第 5 章 全球医疗保健 3D 列印市场(按技术划分)

  • 概述
  • 注射器底座
  • 磁浮
  • 基于雷射
  • 喷墨底座

第6章 全球医疗保健 3D 列印市场(按应用)

  • 概述
  • 熔融沈积成型 (FDM)
  • 选择性激光烧结 (SLS)
  • 立体光刻

第 7 章 全球医疗保健 3D 列印市场(按最终用户)

  • 概述
  • 生物传感器
  • 医疗的
  • 药品
  • 义肢和植入物
  • 组织和器官生成
  • 牙科

第8章全球医疗保健 3D 列印市场(按地区)

  • 概述
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 世界其他地区
    • 拉丁美洲
    • 中东/非洲

第9章全球医疗保健 3D 列印市场:竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第10章 公司简介

  • Cyfuse Biomedical
  • Aprecia Pharmaceuticals
  • Aspect Biosystems
  • Bio 3D Technologies
  • BioBots
  • 3Dynamics Systems
  • Envision TEC
  • Luxexel
  • Materialise NV
  • Nano3D Biosciences
  • Oceanz
  • Organovo Holdings, Inc.
  • regenHU
  • Digilab

第12章 附录

  • 相关研究
简介目录
Product Code: 26454

Healthcare 3D Printing Market Size And Forecast

Healthcare 3D Printing Market size was valued at USD 3.38 Billion in 2023 and is projected to reach USD 12.26 Billion by 2031 growing at a CAGR of 19.29% from 2024 to 2031.

Healthcare 3D printing is the process of making personalized medical items and implants using additive manufacturing. This technique allows for precise, patient-specific solutions in orthopedics, prostheses and surgical planning.

It is used to create implants, prostheses and anatomical models for pre-surgical planning. Personalized implants and surgical instruments enhance patient outcomes and simplify surgical procedures.

Future applications include bioprinting tissues and organs, in addition to prostheses and implants. It offers advances in regenerative medicine and individualized treatment, which could transform how medical diseases are handled and treated.

Global Healthcare 3D Printing Market Dynamics

The key market dynamics that are shaping the global healthcare 3D printing market include:

Key Market Drivers:

Technological Advancements: Advancements in 3D printing technology improve precision, speed and material possibilities, boosting growth by expanding its uses in personalized implants, prostheses and surgical planning.

Rising Demand for Personalized Medicine: As people want personalized healthcare solutions, there is a greater demand for custom-made implants and prostheses adapted to individual patient demands, which is driving market growth.

Growing Incidence of Chronic Diseases: Chronic disease prevalence is increasing, necessitating sophisticated treatment alternatives such as personalized 3D-printed medical equipment, which is driving market demand.

Key Challenges:

Regulatory Obstacles: Navigating several regulations and securing clearances for 3D-printed medical equipment can be difficult and time-consuming, hindering market penetration and product development.

High Costs: High initial costs for 3D printing technology and materials might limit accessibility and uptake, particularly in resource-constrained healthcare settings.

Material Limitations: The number of materials available for 3D printing in healthcare remains limited, reducing the functionality and lifetime of printed medical devices and implants.

Quality and Standardization: Maintaining consistent quality and meeting demanding requirements for 3D-printed medical devices is difficult, compromising reliability and universal adoption in clinical settings.

Key Trends:

Advancements in Bioprinting: Bioprinting advances are allowing for the creation of complex tissues and organ prototypes, pushing the boundaries of regenerative medicine.

Integration with Digital Health Technologies: Combining 3D printing with digital health tools like imaging and CAD software improves precision in medical device manufacture and surgery planning.

Expansion in Emerging Markets: Rising healthcare investments in emerging markets are driving the growth of the 3D printing industry, increasing global access to modern medical technology.

Global Healthcare 3D Printing Market Regional Analysis

Here is a more detailed regional analysis of the global healthcare 3D printing market:

North America:

According to Verified Market Research, North America is expected to dominate the global healthcare 3D printing market.

North America is predicted to dominate the worldwide healthcare 3D printing market due to its strong technological infrastructure, considerable R&D investments and high healthcare spending.

The region's strong emphasis on innovation and individualized medicine, combined with a solid healthcare system and early embrace of cutting-edge technologies, puts it as a pioneer in the development and implementation of 3D printing solutions in healthcare.

Asia Pacific:

According to Verified Market Research, Asia Pacific is fastest growing region in global healthcare 3D printing market.

Asia-Pacific is the fastest-growing region in the worldwide healthcare 3D printing market, owing to rapid advances in medical technology, increasing healthcare investments and rising demand for individualized medical solutions.

The region benefits from expanded healthcare infrastructure and government efforts that promote innovation. increasing usage of 3D printing in medical applications, such as prosthetics and implants, fuels growth, establishing Asia-Pacific as a prominent player in market expansion.

Global Healthcare 3D Printing Market: Segmentation Analysis

The Global Healthcare 3D Printing Market is segmented based on Product, Technology, Application and Geography.

Healthcare 3D Printing Market, By Technology

  • Syringe Based
  • Magnetic Levitation
  • Laser Based
  • Inkjet Based

Based on Technology, the Global Healthcare 3D Printing Market is separated into Syringe Based, Magnetic Levitation, Laser Based, and Inkjet Based. Laser-based technology leads the worldwide healthcare 3D printing market due to its precision, adaptability and capacity to create high-quality, complicated structures for medical implants and equipment.

Healthcare 3D Printing Market, By Application

  • Fused Deposition Modelling (FDM)
  • Selective Laser Sintering (SLS)
  • Stereolithography

Based on Application, Global Healthcare 3D Printing Market is divided into Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), and Stereolithography. Fused Deposition Modeling (FDM) leads the global healthcare 3D printing industry due to its low cost and versatility in producing medical implants, prosthetics and anatomical models.

Healthcare 3D Printing Market, By End-User

  • Biosensors
  • Medical
  • Pharmaceuticals
  • Prosthetics and Implants
  • Tissue and Organ Generation
  • Dental

Based on End-User, Global Healthcare 3D Printing Market is divided into Biosensors, Medical, Pharmaceuticals and Dental. The worldwide healthcare 3D printing market is dominated by prosthetics and implants due to rising demand for individualized medical devices and improvements in materials and technology for tailored patient solutions.

Healthcare 3D Printing Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Healthcare 3D Printing Market divided into North America, Europe, Asia Pacific and Rest of the World. North America leads the global healthcare 3D printing market due to superior technology and high healthcare costs. However, Asia-Pacific is the fastest-growing area, owing to increasing healthcare investments, expanded medical infrastructure and rising demand for individualized medical solutions.

Key Players

  • The Global Healthcare 3D Printing Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are Cyfuse Biomedical, Aprecia Pharmaceuticals, Aspect Biosystems, Bio 3D Technologies, BioBots, 3Dynamics Systems, Envision TEC, Luxexel, Materialise NV, Nano3D Biosciences, Oceanz, Organovo Holdings, Inc., regenHU, Digilab.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

  • Global Healthcare 3D Printing Market Recent Developments
  • In November 2022, Evonik introduces three new INFINAM photopolymers for industrial 3D applications, expanding their photo-resins product portfolio. The product range is designed for use in standard UV-curing 3D printing techniques. The INFINAM RG 2000 L is a photo resin designed for the eyeglass industry.
  • In June 2022, Belgian contract manufacturer Amnovis and medical device service provider BAAT Medical collaborated to deliver an innovative and quick turnaround procedure for 3D-printed medical equipment. Both Amnovis and BAAT Medical have experience 3D printing medical equipment for a variety of certified end-user applications.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL HEALTHCARE 3D PRINTING MARKET

  • 1.1 Introduction of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL HEALTHCARE 3D PRINTING MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY TECHNOLOGY

  • 5.1 Overview
  • 5.2 Syringe Based
  • 5.3 Magnetic Levitation
  • 5.4 Laser Based
  • 5.5 Inkjet Based

6 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Fused Deposition Modelling (FDM)
  • 6.3 Selective Laser Sintering (SLS)
  • 6.4 Stereolithography

7 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Biosensors
  • 7.3 Medical
  • 7.4 Pharmaceuticals
  • 7.5 Prosthetics and Implants
  • 7.6 Tissue and Organ Generation
  • 7.7 Dental

8 GLOBAL HEALTHCARE 3D PRINTING MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL HEALTHCARE 3D PRINTING MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Cyfuse Biomedical
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • Aprecia Pharmaceuticals
  • Aspect Biosystems
  • Bio 3D Technologies
  • BioBots
  • 3Dynamics Systems<
  • Envision TEC
  • Luxexel
  • Materialise NV
  • Nano3D Biosciences
  • Oceanz
  • Organovo Holdings, Inc.
  • regenHU
  • Digilab

12 Appendix

  • 12.1 Related Research